Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2438-2018Class II

Dimension Vista MULTI 2 SDIL, KD694, SMN# 10483586

Siemens Healthcare Diagnostics Inc. / initiated 2018-03-21 / Terminated

Siemens Healthcare Diagnostics, Inc. began a recall of Dimension Vista MULTI 2 SDIL, KD694, SMN# 10483586 on . FDA classified it as Class II and gives the reason as "The diluent may have an incomplete slit on the septum in the cap of the vial. A diluent cap with a defective septum has the potential to cause erroneously elevated results if a sample is autodiluted onboard the system...". As of , the recall status on record is Terminated.

Recall record

Recall number
Z-2438-2018
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Siemens Healthcare Diagnostics Inc.
Product
Dimension Vista MULTI 2 SDIL, KD694, SMN# 10483586
Product code
CDZ Radioimmunoassay, Testosterones And Dihydrotestosterone
Reason for recall
The diluent may have an incomplete slit on the septum in the cap of the vial. A diluent cap with a defective septum has the potential to cause erroneously elevated results if a sample is autodiluted onboard the system, due to a reduced volume of diluent being pipetted from the vial.
FDA root cause
Under Investigation by firm
Action
Notification letters were distributed 3/21/18. The letters instructed customers to: Inspect stock, discontinue use of and discard the Dimension Vista Diluent lots listed in Table 1. Please review this letter with your Medical Director. Review your inventory of these products to determine your laboratorys replacement needs and to provide information to Siemens for reporting to the authorities. Complete and return the Field Correction Effectiveness Check Form attached to this letter within 30 days. If you have received any complaints of illness or adverse events associated with the product listed in Table 1, immediately contact your local Siemens Customer Care Center or your local Siemens Technical Support Representative. Please retain this letter with your laboratory records, and forward this letter to those who may have received this product.
Quantity in commerce
1195
Distribution
The products were distributed to the following US states: AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, and WY. The products were distributed to Guam, Saipan, and Virgin Islands. The products were distributed to the following countries: Australia, Austria, Bahamas, Belgium, Brazil, Canada, Canary Islands, Croatia, Czech Republic, Denmark, France, Germany, Italy, Japan, Lebanon, Netherlands, Poland, Portugal, Qatar, Russian Federation, Slovakia, Slovenia, Saudi Arabia, South Korea, Spain, Switzerland, and United Arab Emirates.
Product codes and lots
lot 7CDA79, UDI # (UDI) 008427680324177CDA7918090110483586, exp 2018-09-01; lot # 7DDA70, UDI # (UDI) 008427680324177DDA7018110110483586, exp 2018-11-01

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2438-2018
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2436-2018Class IITerminatedVoluntary: Firm initiated
Z-2437-2018Class IITerminatedVoluntary: Firm initiated
Z-2438-2018Class IITerminatedVoluntary: Firm initiated